XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Previously Reported [Member]
Convertible Preferred Stock
Convertible Preferred Stock
Previously Reported [Member]
Common Stock
Common Stock
Previously Reported [Member]
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported [Member]
Accumulated Deficit
Accumulated Deficit
Previously Reported [Member]
Accumulated other comprehensive income
Accumulated other comprehensive income
Previously Reported [Member]
Balance at the beginning at Dec. 31, 2020 $ (78,250) $ (78,250)         $ 4,157 $ 4,157 $ (82,642) $ (82,642) $ 235 $ 235
Balance (in Shares) at Dec. 31, 2020         10,376,000 2,124,000            
Balance at the beginning at Dec. 31, 2020     $ 111,432 $ 111,432                
Balance (in Shares) at Dec. 31, 2020     104,822,000 21,458,000                
Retroactive application of exchange ratio, Shares at Dec. 31, 2020       83,364,000   8,252,000            
Stock-based compensation 427           427          
Issuance of Series C Convertible Preferred Stock (in Shares)     16,404,000                  
Issuance of Series C Convertible Preferred Stock     $ 34,793                  
Common stock warrants issued to customers as consideration 22           22          
Common stock warrants related to marketing expense 210           210          
Exercise of warrants 5           5          
Exercise of warrants (in Shares)         2,457              
Net loss (9,267)               (9,267)      
Other comprehensive income (loss) (128)                   (128)  
Balance at the end at Mar. 31, 2021 (86,981)           4,821   (91,909)   107  
Balance (in Shares) at Mar. 31, 2021         12,833              
Balance at the end at Mar. 31, 2021     $ 146,225                  
Balance (in Shares) at Mar. 31, 2021     121,226                  
Balance at the beginning at Dec. 31, 2020 (78,250) $ (78,250)         4,157 $ 4,157 (82,642) $ (82,642) 235 $ 235
Balance (in Shares) at Dec. 31, 2020         10,376,000 2,124,000            
Balance at the beginning at Dec. 31, 2020     $ 111,432 $ 111,432                
Balance (in Shares) at Dec. 31, 2020     104,822,000 21,458,000                
Retroactive application of exchange ratio, Shares at Dec. 31, 2020       83,364,000   8,252,000            
Net loss (19,318)                      
Balance at the end at Jun. 30, 2021 (96,374)           5,416   (101,960)   170  
Balance (in Shares) at Jun. 30, 2021         12,833              
Balance at the end at Jun. 30, 2021     $ 146,225                  
Balance (in Shares) at Jun. 30, 2021     121,226                  
Balance at the beginning at Mar. 31, 2021 (86,981)           4,821   (91,909)   107  
Balance (in Shares) at Mar. 31, 2021         12,833              
Balance at the beginning at Mar. 31, 2021     $ 146,225                  
Balance (in Shares) at Mar. 31, 2021     121,226                  
Stock-based compensation 428           428          
Common stock warrants issued to customers as consideration 18           18          
Common stock warrants related to marketing expense 149           149          
Net loss (10,051)               (10,051)      
Other comprehensive income (loss) 63                   63  
Balance at the end at Jun. 30, 2021 (96,374)           5,416   (101,960)   170  
Balance (in Shares) at Jun. 30, 2021         12,833              
Balance at the end at Jun. 30, 2021     $ 146,225                  
Balance (in Shares) at Jun. 30, 2021     121,226                  
Balance at the beginning at Dec. 31, 2021 449,502       $ 19   604,077   (154,603)   9  
Balance (in Shares) at Dec. 31, 2021         193,864,000              
Balance at the beginning at Dec. 31, 2021                      
Balance (in Shares) at Dec. 31, 2021 0                      
Stock-based compensation $ 3,523           3,523          
Common stock warrants issued to customers as consideration 2           2          
Common stock warrants related to marketing expense 217           217          
Reverse recapitalization, net of transaction costs (70)           (70)          
Exercise of options 62           62          
Number of Options, Exercised         131,000              
ESPP Purchases 488           488          
ESPP Purchases (in shares)         75,000              
Net loss (23,394)               (23,394)      
Other comprehensive income (loss) (183)                   (183)  
Balance at the end at Mar. 31, 2022 430,147       $ 19   608,299   (177,997)   (174)  
Balance (in Shares) at Mar. 31, 2022         194,070,000              
Balance at the beginning at Dec. 31, 2021 449,502       $ 19   604,077   (154,603)   9  
Balance (in Shares) at Dec. 31, 2021         193,864,000              
Balance at the beginning at Dec. 31, 2021                      
Balance (in Shares) at Dec. 31, 2021 0                      
Net loss $ (48,983)                      
Balance at the end at Jun. 30, 2022 404,608       $ 20   608,755   (203,586)   (581)  
Balance (in Shares) at Jun. 30, 2022         197,502,000              
Balance at the end at Jun. 30, 2022                      
Balance (in Shares) at Jun. 30, 2022 0                      
Balance at the beginning at Mar. 31, 2022 $ 430,147       $ 19   608,299   (177,997)   (174)  
Balance (in Shares) at Mar. 31, 2022         194,070,000              
Stock-based compensation 3,823           3,823          
Tax withholdings related to net share settlement of equity awards (3,389)           (3,389)          
Tax withholdings related to net share settlement of equity awards, (in Shares)         (658,000)              
Issuance of common stock upon vesting of equity awards 1       $ 1              
Issuance of common stock upon vesting of equity awards ,(in Shares)         2,151,000              
Common stock warrants issued to customers as consideration 19           19          
Number of Options, Exercised         70,000              
Net settlement related to exercise of options, (in Shares)         (5,000)              
Exercise of warrants 3           3          
Exercise of warrants (in Shares)         1,874,000              
Net loss (25,589)               (25,589)      
Other comprehensive income (loss) (407)                   (407)  
Balance at the end at Jun. 30, 2022 404,608       $ 20   $ 608,755   $ (203,586)   $ (581)  
Balance (in Shares) at Jun. 30, 2022         197,502,000              
Balance at the end at Jun. 30, 2022                      
Balance (in Shares) at Jun. 30, 2022 0